In Treatment of Respiratory tract disorders associated with viscid mucus KUFLITE TABLET helps to loosen thick mucus, making it easier to cough out. This makes it easier for air to move in and out. It will relieve symptoms such as tightness in your chest, shortness of breath, wheezing and coughing and help you carry out your daily activities more easily. This medicine is safe and effective. It usually starts to work within a few minutes and the effects can last up to several hours. Take it as prescribed by the doctor. Do not stop using it unless you are advised to by your doctor. Taking this medicine enables you to live your life more freely without worrying so much about things that set off your symptoms.
It is not known whether it is safe to consume alcohol with KUFLITE TABLET. Please consult your doctor.
KUFLITE TABLET may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of KUFLITE TABLET during breastfeeding is not available. Please consult your doctor.
It is not known whether KUFLITE TABLET alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
KUFLITE TABLET should be used with caution in patients with severe kidney disease. Dose adjustment of KUFLITE TABLET may be needed. Please consult your doctor.
KUFLITE TABLET should be used with caution in patients with liver disease. Dose adjustment of KUFLITE TABLET may be needed. Please consult your doctor.
If you miss a dose of KUFLITE TABLET, skip it and continue with your normal schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Kontest Chemicals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Leeford Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Medicross Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Algen Healthcare Limited || ₹14.5/tablet (25% cheaper)